Maiwei Biological-B (02493) priced its share at HKD 27.64 per share. Public offering was oversubscribed 481.71 times.
Maiwei Biotech-B (02493) announced the results of its distribution, with a global sale of 47.13 million H shares, of which 10% will be publicly offered in Hong Kong and 90% internationally. The sale price per share is HK$27.64, with a total net raising of approximately HK$1.189 billion through global sales. Trading of H shares is expected to commence on the Hong Kong Stock Exchange on Tuesday, April 28, 2026 at 9:00 am (Hong Kong time) with a unit of 200 shares.
Maiwei Bioscience-B (02493) announced the results of its distribution, with the company issuing a total of 47.13 million H shares globally. 10% of the shares were offered for public sale in Hong Kong, while 90% were offered for international sale. The offering price per share was HK$27.64, with net proceeds from the global offering totaling approximately HK$1.189 billion. Each lot consists of 200 shares, and it is expected that trading of H shares on the Stock Exchange of Hong Kong will begin at 9:00 am on Tuesday, April 28, 2026.
The public offering in Hong Kong was oversubscribed 481.71 times, while the international offering was oversubscribed 3.46 times.
Related Articles
Strategy (MSTR.US) adds $255 million worth of Bitcoin, purchasing pace slows significantly compared to the previous two weeks.
US Stock Market Move | "Concept of optical communication widely declines, POET Technologies (POET.US) drops by nearly 45%."
Montage Technology (06809) net profit attributable to shareholders for the first quarter was 847 million yuan, an increase of 61.3% year-on-year.
Strategy (MSTR.US) adds $255 million worth of Bitcoin, purchasing pace slows significantly compared to the previous two weeks.
US Stock Market Move | "Concept of optical communication widely declines, POET Technologies (POET.US) drops by nearly 45%."
Montage Technology (06809) net profit attributable to shareholders for the first quarter was 847 million yuan, an increase of 61.3% year-on-year.
